Studies related to Symptoms of Schizophrenia and Sarcosine

Glycine Transporter I Inhibitor, N-methylglycine (sarcosine), Added To Clozapine For The Treatment Of Schizophrenia

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 20
Sex Both Genders
Age Range 30-44
Notes for this study:
In persons on clozapine, supplementation of sarcosine at 2,000mg daily for 6 weeks has failed to significantly improve symptoms. This is thought to be due to an incompatability with clozapine and additional serinergic/glycinergic signalling rather than a per se fault of sarcosine.

Full details on all 4 studies are available to Examine Plus members.

Already a member? Login now to access.